Detalles de la búsqueda
1.
Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study.
Value Health
; 24(7): 983-994, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34243842
2.
Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments.
Qual Life Res
; 28(8): 2257-2279, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30929124
3.
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma.
J Comp Eff Res
; 12(8): e230004, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431849
4.
Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective.
J Med Econ
; 26(1): 1108-1121, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632452
5.
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.
J Med Econ
; 25(1): 730-740, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611697
6.
Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study.
Eur J Prev Cardiol
; 27(13): 1354-1365, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223323
7.
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model.
Med Decis Making
; 40(8): 1003-1019, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33174513
8.
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 38(5): 431-441, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31701471
9.
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(10): 1195-1207, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30895564
10.
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(5): 655-667, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293207
11.
Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions".
Pharmacoeconomics
; 39(1): 133-135, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33251571
12.
Response to Comment on "Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".
Pharmacoeconomics
; 38(6): 649-651, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249398
Resultados
1 -
12
de 12
1
Próxima >
>>